Product
batiraxcept
1 clinical trial
1 indication
Indication
Pancreatic adenocarcinomaClinical trial
A Phase 1b/2 Randomized Study of AVB-S6-500 Plus Nab-paclitaxel and Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic AdenocarcinomaStatus: Terminated, Estimated PCD: 2023-08-14